Literature DB >> 10472714

The concept of disorder as a foundation for the DSM's theory-neutral nosology: response to Follette and Houts, Part 2.

J C Wakefield1.   

Abstract

Follette and Houts [Follette, W. C., Houts, A. C. (1996). Models of scientific progress and the role of theory in taxonomy development: a case study of the DSM. Journal of Consulting and Clinical Psychology, 64, 1120-1132] argue that 'mental disorder' and 'function' are value concepts that offer no scientific basis for the DSM's theory-neutral nosology or for distinguishing disorders from other behavioral problems. They also claim that the DSM presupposes a biological theory of etiology, thus is not really theory-neutral. They recommend replacing the DSM by theory-laden diagnostic manuals. I argue: (1) DSM criteria do not imply a biological model of disorder, (2) 'mental disorder' and 'function' have scientific content that allows one to distinguish disorder from nondisorder, (3) the evolutionary 'harmful dysfunction' analysis of disorder [Wakefield, J. C. (1992a). The concept of mental disorder: on the boundary between biological facts and social values. American Psychologist, 47, 373-388] coherently demarcates disorder from nondisorder, (4) the proposed behaviorist alternative to the DSM illustrated by the articles in Follette's special section [Follette, W. C. (Ed.) (1996a). Special section on the development of theoretically coherent alternatives to the DSM system. Journal of Consulting and Clinical Psychology, 64, 1117-1201] is incoherent because it does not distinguish disorder from nondisorder.

Entities:  

Mesh:

Year:  1999        PMID: 10472714     DOI: 10.1016/S0005-7967(98)00193-4

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  2 in total

1.  Defining disease beyond conceptual analysis: an analysis of conceptual analysis in philosophy of medicine.

Authors:  Maël Lemoine
Journal:  Theor Med Bioeth       Date:  2013-08

2.  A network theory of mental disorders.

Authors:  Denny Borsboom
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.